Massive hemophilia study aims to uncover hidden costs and care gaps in china
NCT ID NCT07454239
First seen Mar 08, 2026 · Last updated May 12, 2026 · Updated 7 times
Summary
This study is gathering information from 500 male patients aged 12 and older with severe hemophilia A or B in China. Researchers are measuring the disease's burden, treatment costs, and how care varies across different regions and centers. The goal is to identify gaps in care and improve future treatment access, not to test a new drug or cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Instiute of Hematology and Blood Diseases Hospital CAMS＆PUMC
Tianjin, Tianjin Municipality, 300020, China
Conditions
Explore the condition pages connected to this study.